Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
NOVT CORP (NOVT)
|
Add to portfolio |
|
|
|
| Price: |
$675375.00
| | Metrics |
| OS: |
16.3
|
M
| |
-236
|
% ROE
|
| Market cap: |
$11021
|
B
| |
-3810
|
% ROIC
|
|
Net cash:
|
$10.8
|
M
| |
$0.66
|
per share
|
|
EV:
|
$11021
|
B
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
($13.8)
|
M
| |
|
|
| EPS |
($2.08)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-05 | Dec-31-04 | Dec-31-03 | Dec-31-02 | Dec-31-01 | Dec-31-00 | Dec-31-99 | Dec-31-98 |
| Revenues | 7.9 | 23.3 | 62.9 | 69.0 | 69.9 | 6.5 | 1.8 | 0.0 |
| Revenue growth | -66.1% | -63.0% | -8.9% | -1.3% | 970.6% | 258.2% | 9494.7% | |
| Cost of goods sold | 6.0 | 16.1 | 24.3 | 27.3 | 19.2 | 4.3 | 1.6 | 0.1 |
| Gross profit | 1.9 | 7.2 | 38.6 | 41.7 | 50.7 | 2.3 | 0.2 | -0.1 |
| Gross margin | 24.2% | 30.8% | 61.3% | 60.4% | 72.6% | 34.8% | 9.9% | -515.8% |
| Sales and marketing | 4.4 | 12.6 | 19.5 | 26.9 | 34.7 | 15.7 | 6.6 | 3.1 |
| Research and development | 0.7 | 4.6 | 12.0 | 13.3 | 12.8 | 17.1 | 22.9 | 21.1 |
| General and administrative | 10.6 | 8.0 | 8.2 | 8.3 | 9.3 | 6.3 | 3.8 | 2.5 |
| EBIT | -13.8 | -18.1 | -1.1 | -6.8 | -6.0 | -36.8 | -33.1 | -26.8 |
| EBIT margin | -174.6% | -77.7% | -1.8% | -9.8% | -8.6% | -563.8% | -1815.1% | -140994.7% |
| Pre-tax income | -15.3 | -26.9 | -0.9 | -13.1 | -5.1 | -33.1 | -30.9 | -24.7 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -15.3 | -26.9 | -0.9 | -13.1 | -5.1 | -33.1 | -30.9 | -24.7 |
| Net margin | -194.4% | -115.7% | -1.4% | -18.9% | -7.3% | -506.5% | -1696.1% | -129800.0% |
| |
| Diluted EPS | ($3.75) | ($6.59) | ($0.21) | ($0.80) | ($0.32) | ($2.13) | ($2.30) | ($2.34) |
| Shares outstanding (diluted) | 4.1 | 4.1 | 4.1 | 16.3 | 16.2 | 15.5 | 13.4 | 10.5 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|